Kulenthran A
Department of Obstetrics and Gynaecology, University Hospital, Kuala Lumpur, Malaysia.
Med J Malaysia. 1992 Mar;47(1):11-4.
The study was done to assess the efficacy of danazol in the treatment of infertile patients with all stages of endometriosis. The cumulative pregnancy rates in 21 patients with Stage I and II endometriosis were compared to 21 patients with Stage III and IV endometriosis. Both groups had danazol treatment for six months. All other fertility related factors were controlled for in both groups. There was a cumulative pregnancy rate of 11% (standard error 7%) at 12 months of follow-up in the group with Stage I and II disease whilst it was 26% (standard error 10%) in the group with moderate or severe disease. These results question the validity of any classification system in prognosticating for fertility in patients with endometriosis.
该研究旨在评估达那唑治疗各阶段子宫内膜异位症不孕患者的疗效。将21例I期和II期子宫内膜异位症患者的累积妊娠率与21例III期和IV期子宫内膜异位症患者进行比较。两组均接受达那唑治疗6个月。两组中所有其他与生育相关的因素均得到控制。I期和II期疾病组在随访12个月时的累积妊娠率为11%(标准误差7%),而中度或重度疾病组为26%(标准误差10%)。这些结果质疑了任何分类系统在预测子宫内膜异位症患者生育能力方面的有效性。